| ADAMTS | A disintegrin-like and metalloprotease domain with thrombospondin type 1 motifs ALPAlkaline Phosphatase |
| AS | aortic stenosis |
| BMP | bone morphogenetic protein |
| CAVD | calcific aortic valve disease |
| ECM | extracellular matrix |
| EMT | epithelial-mesenchymal transition |
| EndMT | endothelial-mesenchymal transition |
| EVs | extracellular vesicles |
| GAGs | glycosaminoglycans |
| HA | hyaluronic acid |
| HIF-1α | hypoxia inducible factor-1 α |
| ICAM-1 | intercellular adhesion molecule 1 |
| LOX | lysyl oxidase |
| LPS | lipopolysaccharides |
| MMPs | matrix metalloproteinases |
| Msx2 | MshHomeobox 2 |
| MVs | matrix vesicles |
| NGAL | neutrophil gelatinase-associated lipocalin |
| PCSK9 | proprotein convertase subtilisin/kexin type 9 |
| PGC-1α | peroxisome proliferator-activated receptor-γ coactivator 1-α |
| PGs | proteoglycans |
| PO | periostin |
| RHAMM | receptor for hyaluronate-mediated motility |
| RUNX2 | runt-related transcription factor 2 |
| SMCs | smooth muscle cells |
| TAVI | trans-catheter aortic valve implantation |
| TAVR | trans-catheter aortic valve replacement |
| TGF-β | transforming growth factor-β |
| TIMPs | tissue inhibitors of metalloproteinases |
| TNC | tenascin-C |
| TSG-6 | TNF-α stimulated gene-6 |
| VECs | vascular endothelial cells |
| VEGF | vascular endothelial growth factor |
| VICs | vascular interstitial cells |
| α-SMA | α-smooth muscle actin |